Yubi-wakka (Finger-Ring) Test: A Tool to Detect Prefrailty in Elderly Populations, a Pilot Study

Abstract

Background: Preventing frailty of elderly is an urgent issue in Japan. The Yubi-wakka (finger-ring) test was developed and validated as a predictor of sarcopenia, disability and even mortality. To clarify the prevalence of frailty defined by this test and the relationship between other indexes cross-sectionally and prospectively, we conducted this study.

Methods: Five thousand four hundred and five subjects who were 65 to 74 years old participated in this study. In a sitting position, the subjects surrounded their calf using their own finger-ring, and whether the calf was larger, just fit, or smaller than the finger-ring was determined. We analyzed these Yubi-wakka (finger-ring) test results and other clinical indexes. We used Students t-tests and the Chi-squared tests to compare the data between the groups, and logistic regression tests to adjust for multiple variables.

Results: In total, 38.8% of the subjects calves were judged as being larger, 45.6% as just fit and 15.6% as smaller, which was the positive test result. The positive rate differed among medical facilities without any known different characteristics. The comparison between the larger and smaller groups revealed that body weight, red blood cell count, serum lipids, uric acid and liver enzymes were significantly different between the groups. Metabolic syndrome was more common in the larger group. In multiple analysis, low body mass index was an independent risk factor in both sexes. Positive urinary glucose, higher aspartate aminotransferase, systolic blood pressure and low alanine transaminase were risk factors for positive test results for males. Smoking, high hemoglobin and old age were risk factors for positive test results in females.

Conclusions: The test was simple and feasible enough for the primary care setting, without the requirement of any devices. However, the positive rate varied among the clinics. The subjects age was limited to under 75 years, and the test possibly detected individuals without metabolic syndrome and fatty liver. We are also planning to increase the subjects age range and collect data prospectively.

J Clin Med Res. 2019;11(9):623-628
doi: https://doi.org/10.14740/jocmr3917